CVS Health Corporation (CVS)
CVS cuts bonuses after low profit levels in 2024
CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare conglomerate grapples with higher costs across its Medicare plans.
This stock is up 50% already since Jim Cramer's warning
Jim Cramer, the eccentric host of ‘Mad Money' on CNBC, is one of the most recognizable voices covering finance in the United States. Recognizable, however, does not necessarily equate to reverence.
Top 2 cheap stocks to buy for 2025
The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage levels. CVS' Q4 results showed a surprising EBIT margin beat, but continued margin erosion in its insurance business remains a concern. Improved margin performance in FY25 is possible with better insurance policy terms and reduced loss-making membership counts but given a poor execution record, it is better to wait for evidence.
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
After underperforming throughout 2024, shares of CVS Health (CVS -0.81%) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.
CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?
CVS Health's adjusted EPS outlook for 2025 reflects expectations of a meaningful recovery in Medicare Advantage and continued growth in Health Services.
Why CVS Stock Thrashed the Market on Thursday
For the second day in a row, CVS Health's (CVS 4.98%) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a series of analyst price target raises.
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
CVS shares are up 45% this year — here's why it may be starting to turn its business around
CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and Cigna.
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
CVS Health: Earnings Beat Ignites Stock Rally
Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline, causing investors to question whether this is a temporary upswing or a sign of a genuine turnaround.
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.
